NCT04830618View on ClinicalTrials.gov

Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 11, 2012

Primary Completion Date

November 16, 2017

Study Completion Date

December 31, 2020

Conditions
Metachronous NeoplasmGastric CancerGastric NeoplasmAberrant DNA Methylation
All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04830618 - Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms | Biotech Hunter | Biotech Hunter